Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tang-Du Hospital
With
LinkDoc Technology (Beijing) Co. Ltd.
The is a multi-center retrospective study. Patients with pathologic N2 NSCLC who underwent VATS or open lobectomy between 2014 and 2017 were included into this study. Clinical data on patient demographic, clinical characteristics, treatment and clinical outcomes will be collected to evaluate the safety and effectiveness of video-assisted thoracoscopic lobectomy for pathologic N2 NSCLC.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with age \> 18 years old;
Patients with pathologically diagnosed non-small cell lung cancer;
Patients underwent lobectomy by either VATS or thoracotomy between 2014 and 2017;
Patients who received lymphadenectomy for all accessible lymph nodes;
Patients with N2 lymph nodes (+) after surgeries;
You may not be if
Patients with second primary tumors or multiple primary tumors;
Patients who received chest surgeries before hospitalization;